Nexavar, Sorafenib 200 mg 112 tab. Original, Baxter Hepatocellular carcinoma (HCC). Differentiated thyroid cancer (DTC). Targeted cancer therapy. Order medications from Europe by calling +380996042415.
Price upon request
Interchangeable drugs with the same active ingredient:
- Nescavar
- Sorafenate
- Sorafenib
- Sarafenib
Indications
Renal cell carcinoma (RCC).
- Nexavar is indicated for the treatment of patients with advanced renal cell carcinoma.
Hepatocellular carcinoma (HCC).
- Nexavar is indicated for the treatment of patients with unresectable hepatocellular carcinoma.
Differentiated thyroid cancer (Thyroid cancer).
- Nexavar is indicated for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid cancer refractory to radioactive iodine therapy.
- Trade Name:Nexavar
- Chemical Name:Sorafenib
- Dosage:200 mg
- Quantity:112
- Form of Issue:Tablets
No reviews yet